logo

For the Inventor, By the Inventor

Irvine, CA, United States of America

Ling Li

This inventor holds 38 USPTO granted patents and 11 published patent applications and 8 EPO patents, primarily in Sphingosine Receptor Modulators. Top assignee: Allergan, Inc.. Active years: 2005-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ling Li. Retrieved from https://idiyas.com/inventor/ling-li-3919zqh8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 

% Patents Active = 23.7

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal38 out of 2,287 
 
Allergan, Inc.
 patents

Years Active: 2005-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Sphingosine-1-Phosphate
Oxadiazoles
Pyrazole Derivatives
Azetidine
Adrenergic Agents
Bicyclic Compounds
Inhibitory Activity
Selective Modulators
Phosphonic Acids
Phenyl Compounds
Dihydropyrazoles
Cytochrome P450
38 patents (USPTO):Explore Patents
1. 11208377 - 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof (2021-12-28),
2. 9371296 - Bicyclic 1,3,4-oxadiazole derivatives as sphingosine-1-phosphate receptors' modulators (2016-06-21),
3. 9120784 - 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators (2015-09-01),
4. 9108993 - Pyrazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators (2015-08-18),
5. 9062030 - Pyrazole azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators (2015-06-23),
6. 9000016 - 1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators (2015-04-07),
7. 8987471 - Substituted dihydropyrazoles as sphingosine receptor modulators (2015-03-24),
8. 8987467 - Substituted pyrazole azetidines as sphingosine receptor modulators (2015-03-24),
9. 8957051 - Bicyclic 1, 2, 4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators (2015-02-17),
10. 8946195 - Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators (2015-02-03),
11. 8859598 - 1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators (2014-10-14),
12. 8846729 - 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators (2014-09-30),
13. 8809379 - Selective subtype alpha 2 adrenergic agents and methods for use thereof (2014-08-19),
14. 8735399 - Selective subtype alpha 2 adrenergic agents and methods for use thereof (2014-05-27),
15. 8729110 - 2-thio-1,3,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators (2014-05-20),

Title: Ling Li: Pioneering Inventor from Irvine

Introduction: Ling Li is a trailblazing inventor based in Irvine, California. With a passion for innovation and a drive to make a difference, she has made significant contributions to the field of technology.

Latest Patents: Ling Li holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies. Her recent patents focus on enhancing the efficiency of solar panels and developing smart grid solutions.

Career Highlights: Throughout her career, Ling Li has worked with leading tech companies to bring cutting-edge products to the market. Her expertise in renewable energy has led to breakthroughs in solar technology, making clean energy more accessible and affordable.

Collaborations: Ling Li has collaborated with top researchers and engineers in the industry to push the boundaries of innovation. Her partnerships with universities and research institutions have resulted in groundbreaking projects that have the potential to shape the future of technology.

Conclusion: Ling Li's dedication to innovation and her commitment to sustainability have established her as a prominent figure in the world of inventors. Her work continues to inspire the next generation of innovators to create a more sustainable and technologically advanced world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…